Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × plerixafor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 5 Multiple Myeloma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Sarcoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Myeloproliferative Disorders 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Colorectal Neoplasms 1 Astrocytoma 1

Interventions

Doxorubicin 23 Cyclophosphamide 23 Gemcitabine 14 Radiotherapy 11 Filgrastim 11 pazopanib 10 Cisplatin 9 pembrolizumab 8 Docetaxel 8 Radiation 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Busulfan 7 fludarabine 6 Trabectedin 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Melphalan 6 Ipilimumab 6 Etoposide 6 Carboplatin 6 Bevacizumab 6 selinexor 5 olaratumab 4 aflibercept 4 Topotecan 4 Thiotepa 4 Temozolomide 4 Nivolumab 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240861 2023-11-01

NYESO SCT

Jonsson Comprehensive Cancer Center

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡